ExcepGen secures $14M seed funding to develop new mRNA technology
Longevity Technology - 04-Oct-2023Technology could make mRNA vaccines and therapeutics more effective and safer
ExcepGen
Solving fundamental underlying problems in drug discovery to create a new generation of therapeutics
ExcepGen stands as the pioneering entity in the field of mRNA cellular interaction engineering. The company's unique platform possesses the capability to modify cellular responses to therapeutic mRNA. This alteration involves the suppression of undesirable cellular pathways while amplifying those deemed beneficial.
Visit website: https://www.excepgen.com/
Details last updated 07-Oct-2023
ExcepGen News
